| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJMOA060992 |
| P698 | PubMed publication ID | 17005948 |
| P50 | author | Donald Morton | Q16019759 |
| Robert Elashoff | Q78177958 | ||
| Nicola Mozzillo | Q110644242 | ||
| P2093 | author name string | Brendon J Coventry | |
| John F Thompson | |||
| Harald J Hoekstra | |||
| Alistair J Cochran | |||
| Douglas S Reintgen | |||
| He-Jing Wang | |||
| Omgo E Nieweg | |||
| Richard Essner | |||
| Edwin C Glass | |||
| Daniel F Roses | |||
| Constantine P Karakousis | |||
| MSLT Group | |||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biopsy | Q179991 |
| P304 | page(s) | 1307-1317 | |
| P577 | publication date | 2006-09-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Sentinel-node biopsy or nodal observation in melanoma. | |
| P478 | volume | 355 |
| Q38858547 | "Stealth" melanoma cells in histology-negative sentinel lymph nodes. |
| Q49015294 | A 10-year analysis of primary cutaneous malignant melanoma with sentinel lymph node biopsy and long-term follow-up |
| Q36278044 | A Comparison of Radiocolloid and Indocyanine Green Fluorescence Imaging, Sentinel Lymph Node Mapping in Patients with Cervical Cancer Undergoing Laparoscopic Surgery. |
| Q34259205 | A brief history of melanoma: from mummies to mutations |
| Q53627935 | A case of trichilemmal carcinoma with distant metastases in a kidney transplantation patient. |
| Q35181020 | A comparison of merkel cell carcinoma and melanoma: results from the california cancer registry. |
| Q38261443 | A method to estimate treatment efficacy among latent subgroups of a randomized clinical trial |
| Q37442420 | A multimarker prognostic assay for primary cutaneous melanoma |
| Q37445185 | A neoadjuvant biochemotherapy approach to stage III melanoma: analysis of surgical outcomes |
| Q34766085 | A phase 2 study of (99m)Tc-tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer |
| Q40457217 | A population-based assessment of melanoma: Does treatment in a regional cancer center make a difference? |
| Q30275914 | A retrospective analysis of the role of adjuvant radiotherapy in the treatment of cutaneous melanoma |
| Q38264727 | A review of sentinel lymph node biopsy for thin melanoma |
| Q90979179 | A semiparametric linear transformation model to estimate causal effects for survival data |
| Q28728722 | A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts |
| Q37850827 | AJCC melanoma staging update: impact on dermatopathology practice and patient management |
| Q33754941 | Aberrant fatty acid-binding protein-7 gene expression in cutaneous malignant melanoma |
| Q35989635 | Aberrant hypermethylation in primary tumours and sentinel lymph node metastases in paediatric patients with cutaneous melanoma |
| Q34898020 | Acral lentiginous melanoma: a case control study and guidelines update. |
| Q30492895 | Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer |
| Q27025460 | Adjunct primer for the use of national comprehensive cancer network guidelines for the surgical management of cutaneous malignant melanoma patients |
| Q34986199 | Adjuvant Immunotherapy and Radiation in the Management of High-risk Resected Melanoma. |
| Q37080022 | Adjuvant radiotherapy for cutaneous melanoma |
| Q37984125 | Advances in sentinel lymph node mapping for patients with melanoma |
| Q48298793 | Advantages of preoperative hybrid SPECT/CT in detection of sentinel lymph nodes in cutaneous head and neck malignancies. |
| Q53157301 | Advantages of preoperative ultrasound in conjunction with lymphoscintigraphy in detecting malignant melanoma metastases in sentinel lymph nodes: a retrospective analysis in 221 patients with malignant melanoma AJCC Stages I and II. |
| Q40119372 | Age and gender are significant independent predictors of survival in primary cutaneous melanoma. |
| Q55179525 | Analysis of patients diagnosed with primary cutaneous melanoma in the last six years in Hospital Erasto Gaertner: epidemiologic profile*. |
| Q38030894 | Analysis of regional recurrence after negative sentinel lymph node biopsy for head and neck melanoma |
| Q91390736 | Animal-type melanoma: dog or wolf? A review of the literature and a case report |
| Q38877852 | Assessment of morbidity following regional nodal dissection in the axilla and groin for metastatic melanoma. |
| Q38671823 | Association Between Patient Age and Lymph Node Positivity in Thin Melanoma |
| Q34958225 | Association of sentinel lymph node biopsy with survival for head and neck melanoma: survival analysis using the SEER database |
| Q38201569 | Atypical Spitz tumours and sentinel lymph node biopsy: a systematic review. |
| Q80212096 | Authors' response to a letter to the editor re: Sentinel node biopsy for early-stage melanoma |
| Q40566495 | Availability of sentinel lymph node biopsy for cutaneous squamous cell carcinoma |
| Q47282554 | Bacterial nanocellulose-IKVAV hydrogel matrix modulates melanoma tumor cell adhesion and proliferation and induces vasculogenic mimicry in vitro |
| Q89017223 | Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma? |
| Q26770492 | Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition) |
| Q58028648 | Chirurgische Therapie des malignen Melanoms |
| Q39746034 | Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patients |
| Q38215042 | Clinical impact of biopsy method on the quality of surgical management in melanoma |
| Q88133995 | Clinical significance of tumor mitotic rate and lack of epidermal attachment in melanoma of the head and neck |
| Q26747723 | Clinical utilities and biological characteristics of melanoma sentinel lymph nodes |
| Q37920833 | Clinically relevant information from sentinel lymph node biopsies of melanoma patients |
| Q50122047 | Clinicopathologic Factors Predictive of Occult Lymph Node Involvement in Cutaneous Head and Neck Melanoma |
| Q43501351 | Clinicopathologic prognostic markers of survival: an analysis of 259 patients with malignant melanoma >or=1 mm. |
| Q89726549 | Clinicopathological Features, Staging, and Current Approaches to Treatment in High-Risk Resectable Melanoma |
| Q36578086 | Combined analysis of phase III trials evaluating [⁹⁹mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma |
| Q48331795 | Comparative effectiveness in melanoma |
| Q33722305 | Comparative genomic hybridization for the diagnosis of melanoma |
| Q38151728 | Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review. |
| Q44864766 | Comparison of the use and results of sentinel lymph node biopsy in children and young adults with melanoma |
| Q40681400 | Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial |
| Q64326294 | Complete lymphadenectomy following positive sentinel lymph node biopsy in cutaneous melanoma: a critical review |
| Q38738044 | Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. |
| Q47746110 | Completion Lymph Node Dissection or Observation for Melanoma Sentinel Lymph Node Metastases: A Decision Analysis |
| Q35148157 | Concomitant sentinel lymph node biopsy leading to abbreviated systematic lymphadenectomy in a patient with primary malignant melanoma of the vagina |
| Q36447112 | Confirmation of sentinel lymph node identity by analysis of fine-needle biopsy samples using inductively coupled plasma-mass spectrometry |
| Q36615052 | Conjunctival melanoma and melanocytic intra-epithelial neoplasia. |
| Q40305742 | Correlation between theoretical anatomical patterns of lymphatic drainage and lymphoscintigraphy findings during sentinel node detection in head and neck melanomas |
| Q47879600 | Cost-effectiveness of preoperative SPECT/CT combined with lymphoscintigraphy vs. lymphoscintigraphy for sentinel lymph node excision in patients with cutaneous malignant melanoma |
| Q37920844 | Current and planned multicenter trials for patients with primary or metastatic melanoma |
| Q37139142 | Current clinical overview of cutaneous melanoma |
| Q34610427 | Current concepts of metastasis in melanoma. |
| Q37983934 | Current management and novel agents for malignant melanoma |
| Q39764476 | Current management of advanced resectable oral cavity squamous cell carcinoma |
| Q33649990 | Current status and challenges in sentinel node navigation surgery for early gastric cancer |
| Q36668237 | Current surgical management of melanoma |
| Q28078576 | Cutaneous Melanoma in Asians |
| Q43800535 | Cutaneous apocrine adenocarcinoma: defining epidemiology, outcomes, and optimal therapy for a rare neoplasm |
| Q37118944 | Cutaneous head and neck melanoma: the old and the new. |
| Q56897036 | Cutaneous melanoma |
| Q37568972 | Cutaneous melanoma in the era of molecular profiling |
| Q34642874 | Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up |
| Q37863622 | Cutaneous melanoma: a model to study cancer metastasis |
| Q84626088 | Cutting a sentinel lymph node into slices is the optimal first step for examination of sentinel lymph nodes in melanoma patients |
| Q80978504 | Defining the highway of lymphatic patterns for melanoma |
| Q36997179 | Dermal melanoma: A report on prognosis, outcomes, and the utility of sentinel lymph node biopsy |
| Q37779991 | Dermatopathology of skin cancer in solid organ transplant recipients |
| Q53511360 | Dermoscopy for melanoma: don't forget to take a photo. |
| Q50456824 | Dermoscopy structures as predictors of sentinel lymph node positivity in cutaneous melanoma. |
| Q91719728 | Desmoplastic melanoma: The role of pure and mixed subtype in sentinel lymph node biopsy and survival |
| Q35854842 | Desmoplastic melanoma: is there a role for sentinel lymph node biopsy? |
| Q34597707 | Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 cases |
| Q35859015 | Detection of Merkel cell virus and correlation with histologic presence of Merkel cell carcinoma in sentinel lymph nodes. |
| Q40901882 | Detection of circulating melanoma cells in the blood of melanoma patients: a preliminary study |
| Q30434819 | Detection of melanoma metastases in resected human lymph nodes by noninvasive multispectral photoacoustic imaging. |
| Q88946303 | Detection of melanoma metastases with the sentinel node biopsy: the legacy of Donald L. Morton, MD (1934-2014) |
| Q79862509 | Detection of tyrosinase mRNA in the sentinel lymph nodes of melanoma patients is not a predictor of short-term disease recurrence |
| Q84522316 | Diagnostic utility of IMP3 in segregating metastatic melanoma from benign nevi in lymph nodes |
| Q84814732 | Diagnostic utility of neural stem and progenitor cell markers nestin and SOX2 in distinguishing nodal melanocytic nevi from metastatic melanomas |
| Q50273015 | Diagnostic value of intraoperative examination of sentinel lymph node in early cervical cancer: a prospective, multicenter study |
| Q36267269 | Differential gene expression of primary cultured lymphatic and blood vascular endothelial cells. |
| Q46594525 | Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases |
| Q37063136 | Dilemma of clinically node-negative head and neck melanoma: outcome of "watch and wait" policy, elective lymph node dissection, and sentinel node biopsy--a systematic review |
| Q38441450 | Dissection of immune gene networks in primary melanoma tumors critical for antitumor surveillance of patients with stage II-III resectable disease |
| Q37794026 | Distant metastases do not metastasize |
| Q48436363 | Donald L. Morton, MD … a living legend in surgical oncology |
| Q34161700 | Dramatic innovations in modern surgical subspecialties |
| Q50083456 | Dynamic 18F-FDG PET Lymphography for In Vivo Identification of Lymph Node Metastases in Murine Melanoma |
| Q47630726 | EANM-EORTC general recommendations for sentinel node diagnostics in melanoma |
| Q37672467 | Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases : personal experience and literature meta-analysis. |
| Q46136921 | Effective low-dose escalation of indocyanine green for near-infrared fluorescent sentinel lymph node mapping in melanoma |
| Q55392419 | Efficacy of repeat sentinel lymph node biopsy in patients who develop recurrent melanoma. |
| Q36110293 | Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanoma |
| Q37134426 | Emerging therapies for melanoma |
| Q42629898 | Enhanced postoperative lymphatic staging of malignant melanoma by endoscopically assisted iliacoinguinal dissection |
| Q35876127 | Epidemiological profile of patients with cutaneous melanoma in a region of southern Brazil |
| Q37689491 | Epidemiology and treatment of melanoma in elderly patients |
| Q37478182 | Epigenetic regulation of REG1A and chemosensitivity of cutaneous melanoma. |
| Q38017604 | Epigenetics of regional lymph node metastasis in solid tumors. |
| Q36008558 | Epitrochlear sentinel lymph nodes in melanoma: interval or independent? |
| Q64957678 | Establishment of a model of sentinel lymph node metastasis using immunodeficient swine. |
| Q35005677 | Evaluating biomarkers in melanoma. |
| Q92277732 | Evaluation of Chest Radiographs and Laboratory Testing during Melanoma Staging Procedures |
| Q40888963 | Evaluation of a radioactive and fluorescent hybrid tracer for sentinel lymph node biopsy in head and neck malignancies: prospective randomized clinical trial to compare ICG-(99m)Tc-nanocolloid hybrid tracer versus (99m)Tc-nanocolloid. |
| Q43592024 | Evaluation of incomplete sentinel node biopsy procedures and sentinel node positivity rates as surgical quality-assurance parameters in melanoma patients. |
| Q91576665 | Evaluation of lymph node metastasis in a rabbit tumor model: correlations between contrast-enhanced ultrasound and pathologic findings |
| Q30433911 | Evaluation of the sentinel immunized node for immune monitoring of cancer vaccines |
| Q37920828 | Evidence-based treatment of early-stage melanoma |
| Q85043057 | Evolving treatment strategies in thin cutaneous head and neck melanoma: 1 institution's experience |
| Q38788856 | Excision margins and sentinel lymph node status as prognostic factors in thick melanoma of the head and neck: A retrospective analysis |
| Q56890792 | Exploring the role of stromal osmoregulation in cancer and disease using executable modelling |
| Q90656099 | Expression of CMV protein pp65 in cutaneous malignant melanoma |
| Q44184973 | Factors influencing the use of sentinel lymph node biopsy in the Netherlands. |
| Q42535686 | False-negative sentinel node biopsy |
| Q47621555 | Favourable prognostic role of histological regression in stage III positive sentinel lymph node melanoma patients |
| Q50283098 | Feasibility of ICG fluorescence-guided sentinel node biopsy in animal models using the HyperEye Medical System |
| Q33760173 | Final trial report of sentinel-node biopsy versus nodal observation in melanoma |
| Q37682482 | Fine-needle biopsy of metastatic melanoma: clinical use and new applications |
| Q34377308 | First experiences of photoacoustic imaging for detection of melanoma metastases in resected human lymph nodes. |
| Q53243638 | Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node. |
| Q26999904 | Follow-up in melanoma patients |
| Q57138060 | Gamma probe and ultrasound-guided fine needle aspiration cytology of the sentinel node (GULF) trial |
| Q37002454 | Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression |
| Q36368420 | Geographic variation in utilization of sentinel lymph node biopsy for intermediate thickness cutaneous melanoma |
| Q47651415 | Head and neck cutaneous melanoma: a retrospective observational study on 146 patients. |
| Q40829184 | High molecular weight-melanoma-associated antigen as a biomarker of desmoplastic melanoma |
| Q35855182 | High nevus counts confer a favorable prognosis in melanoma patients. |
| Q38078224 | How often do level III nodes bear melanoma metastases and does it affect patient outcomes? |
| Q42152636 | How should we view the results of the Multicenter Selective Lymphadenectomy Trial-1 (MSLT-1)? |
| Q38426349 | Human high molecular weight-melanoma-associated antigen: utility for detection of metastatic melanoma in sentinel lymph nodes |
| Q81957700 | Hypothesis letter: The reason sentinel and lymph node dissections do not improve melanoma mortality |
| Q79670956 | IFHNOS Global Continuing Education Program. Current concepts in head & neck surgery and oncology 2008 |
| Q80513333 | IMP-3 is a novel progression marker in malignant melanoma |
| Q89529822 | Identification of Cancer Stem Cell Subpopulations in Head and Neck Metastatic Malignant Melanoma |
| Q36420692 | Identification of Patients with Intermediate Thickness Melanoma at Low Risk for Sentinel Lymph Node Positivity |
| Q37708403 | Image-guided sentinel lymph node mapping and nanotechnology-based nodal treatment in lung cancer using invisible near-infrared fluorescent light. |
| Q33416415 | Imaging of lymph node micrometastases using an oncolytic herpes virus and [F]FEAU PET. |
| Q36739767 | Immunotherapy of melanoma: a critical review of current concepts and future strategies |
| Q37047961 | Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma |
| Q39199308 | Impact of mitotic activity on the pathological substaging of pT1 cutaneous melanoma |
| Q37863618 | Impact of nodal status and tumor burden in sentinel lymph nodes on the clinical outcomes of cancer patients. |
| Q52946964 | Impact of the 2009 AJCC staging guidelines for melanoma on the number of mitotic figures reported by dermatopathologists at one institution. |
| Q37618735 | Impact of the false-negative sentinel lymph node biopsy in melanoma |
| Q61927979 | Implications of a positive sentinel node in oral squamous cell carcinoma |
| Q36923881 | Importance of sentinel lymph node biopsy in patients with thin melanoma |
| Q33611835 | Importance of tumor load in the sentinel node in melanoma: clinical dilemmas |
| Q48348150 | Improvement and persistent disparities in completion lymph node dissection: Lessons from the National Cancer Database. |
| Q50235183 | Improvement of the sentinel lymph node detection rate of cervical sentinel lymph node biopsy using real-time fluorescence navigation with indocyanine green in head and neck skin cancer |
| Q38010798 | Improving triage and management of patients with skin cancer: challenges and considerations for the future. |
| Q48082938 | In memoriam: Donald L. Morton, MD (1934-2014): an icon in surgical oncology : past president, society of surgical oncology (1992-1993) and associate editor, annals of surgical oncology (1993-2014). |
| Q51713740 | In vivo visualization of mesoscopic anatomy of healthy and pathological lymph nodes using 7T MRI: a feasibility study. |
| Q50629099 | In-transit melanoma metastases: incidence, prognosis, and the role of lymphadenectomy. |
| Q46595037 | Incomplete sentinel node biopsy is not clearly related to survival or regional recurrence in cutaneous melanoma patients |
| Q94602345 | Increase of sentinel lymph node melanoma staging in The Netherlands; still room and need for further improvement |
| Q42560491 | Increasing Age Is Associated with Worse Prognostic Factors and Increased Distant Recurrences despite Fewer Sentinel Lymph Node Positives in Melanoma |
| Q35892462 | Indications of Sentinel Node Biopsy in Thin Melanoma |
| Q36745143 | Individualized surgery: gamma-probe-guided lymphadenectomy in patients with clinically enlarged lymph node metastases from melanomas |
| Q50222966 | Indocyanine green and fluorescence lymphangiography for sentinel lymph node identification in cutaneous melanoma |
| Q48958354 | Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm |
| Q50185704 | Indocyanine green-assisted sentinel lymph node biopsy in melanoma using the "FOVIS" system |
| Q38180632 | Inflammation-induced lymphangiogenesis and lymphatic dysfunction |
| Q53648715 | Infrared imaging of primary melanomas reveals hints of regional and distant metastases. |
| Q37871922 | Inguinopelvic lymphadenectomy following positive inguinal sentinel lymph node biopsy in melanoma: true frequency of synchronous pelvic metastases |
| Q27311384 | Inhibition of VEGF-C modulates distal lymphatic remodeling and secondary metastasis |
| Q24201908 | Interferon alpha for the adjuvant treatment of cutaneous melanoma |
| Q38195330 | Interferon alpha for the adjuvant treatment of melanoma: review of international literature and practical recommendations from an expert panel on the use of interferon |
| Q58747512 | Interferon is associated with improved survival for node-positive cutaneous melanoma: a single-institution experience |
| Q37399871 | Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma. |
| Q35089936 | Interval sentinel lymph nodes: an unusual localization in patients with cutaneous melanoma |
| Q64907472 | Intraoperative Imaging with a Portable Gamma Camera May Reduce the False-Negative Rate for Melanoma Sentinel Lymph Node Surgery. |
| Q36994123 | Intraoperative mapping of sentinel lymph node metastases using a clinically translated ultrasmall silica nanoparticle |
| Q37413410 | Is Sentinel lymph node biopsy profitable in melanoma patients? |
| Q45130708 | Is head and neck melanoma different from trunk and extremity melanomas with respect to sentinel lymph node status and clinical outcome? |
| Q43597201 | Is sentinel node biopsy the standard of care in melanoma management? The opinions and practices of Australian specialists |
| Q26750741 | Is there a relation between type of primary melanoma treatment and the development of intralymphatic metastasis? A review of the literature |
| Q38966445 | Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients. |
| Q43090910 | Isolated tumor cells and long-term prognosis of patients with melanoma |
| Q36990701 | Issues affecting molecular staging in the management of patients with melanoma |
| Q50468123 | Laparoscopic sentinel lymph node mapping for cervix cancer--a detailed evaluation and time analysis |
| Q39736645 | Latent subgroup analysis of a randomized clinical trial through a semiparametric accelerated failure time mixture model |
| Q56828381 | Lentigos, Melanocytic Naevi and Melanoma |
| Q51868749 | Less false-negative sentinel node procedures in melanoma patients with experience and proper collaboration. |
| Q92269886 | Level of Evidence Review for a Gene Expression Profile Test for Cutaneous Melanoma |
| Q38031760 | Local targets for immune therapy to cancer: tumor draining lymph nodes and tumor microenvironment |
| Q38005673 | Long-term prognosis and significance of the sentinel lymph node in head and neck melanoma |
| Q33682108 | Long-term survival analysis and clinical follow-up in acral lentiginous malignant melanoma undergoing sentinel lymph node biopsy in korean patients |
| Q53055722 | Low predictive value of sentinel lymph node biopsy in patients with thin melanoma. |
| Q30558101 | Lower tumour burden and better overall survival in melanoma patients with regional lymph node metastases and negative preoperative ultrasound |
| Q37090076 | Lymph Node Micrometastases and In-Transit Metastases from Melanoma: In Vivo Detection with Multispectral Optoacoustic Imaging in a Mouse Model |
| Q88733680 | Lymph node metastasis in melanoma: a debate on the significance of nodal metastases, conditional survival analysis and clinical trials |
| Q83519372 | Lymph node ratio in melanoma: A marker of variation in surgical quality? |
| Q37370769 | Lymph node ratio predicts disease-specific survival in melanoma patients |
| Q61813951 | Lymph node resection induces the activation of tumor cells in the lungs |
| Q36689098 | Lymphadenectomy promotes tumor growth and cancer cell dissemination in the spontaneous RET mouse model of human uveal melanoma |
| Q33940058 | Lymphangiogenesis and lymphatic metastasis in breast cancer |
| Q88886615 | Lymphangiogenesis, lymphatic systemomics, and cancer: context, advances and unanswered questions |
| Q38136250 | Lymphatic function and immune regulation in health and disease |
| Q39311070 | Lymphatic invasion as a prognostic biomarker in primary cutaneous melanoma |
| Q35685833 | Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanoma |
| Q36773900 | Lymphatic invasion predicts aggressive behavior in melanocytic tumors of uncertain malignant potential (MELTUMP). |
| Q36779185 | Lymphatic invasion revealed by multispectral imaging is common in primary melanomas and associates with prognosis |
| Q38064829 | Lymphatic vessels in health and disease |
| Q41600452 | Lymphatics, lymph nodes and the immune system: barriers and gateways for cancer spread |
| Q55295560 | Malignant Melanoma of the Nipple: A Case Report. |
| Q54432652 | Malignant Melanoma. |
| Q35898742 | Malignant melanoma (non-metastatic): sentinel lymph node biopsy |
| Q37878331 | Malignant melanoma of the head and neck: a brief review of pathophysiology, current staging, and management |
| Q57571783 | Management of Melanoma |
| Q97880448 | Management of Melanoma Patients with Positive Nodes |
| Q34667481 | Management of conjunctival malignant melanoma: a review and update |
| Q37045213 | Management of cutaneous melanoma: a public health and individual patient care perspective |
| Q38246243 | Management of melanoma |
| Q35068833 | Management of popliteal sentinel nodes in melanoma |
| Q34900273 | Management of primary melanoma of the female urogenital tract |
| Q34986232 | Management of regional lymph node basins in melanoma |
| Q85074420 | Management of the Difficult Sentinel Lymph Node in Patients With Primary Cutaneous Melanoma |
| Q56828365 | Melanocytic Naevi and Melanoma |
| Q37605787 | Melanoma biomarkers: current status and utility in diagnosis, prognosis, and response to therapy |
| Q34998750 | Melanoma characteristics in Brazil: demographics, treatment, and survival analysis |
| Q33554622 | Melanoma in pediatric, adolescent, and young adult patients |
| Q44216767 | Melanoma patients with an unknown primary tumor site have a better outcome than those with a known primary following therapeutic lymph node dissection for macroscopic (clinically palpable) nodal disease |
| Q34255928 | Melanoma sentinel node biopsy and prediction models for relapse and overall survival |
| Q36961188 | Melanoma survival in the United States, 1992 to 2005. |
| Q37886997 | Melanoma update: diagnostic and prognostic factors that can effectively shape and personalize management. |
| Q87682230 | Melanoma: MSLT-1--putting sentinel lymph node biopsy into context |
| Q64990433 | Melanoma: Why is sentinel lymph node biopsy 'standard of care' for melanoma? |
| Q34631014 | Merkel cell carcinoma: critical review with guidelines for multidisciplinary management |
| Q37463192 | Meta-analysis of sentinel lymph node positivity in thin melanoma ( |
| Q34207433 | Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas |
| Q34286994 | Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I) |
| Q50540269 | Metastatic Melanoma in Sentinel Node-Negative Patients: The Ottawa Experience. |
| Q42439316 | Metastatic basosquamous carcinoma detected by sentinel lymph node biopsy |
| Q39024316 | Metastatic pathways in patients with cutaneous melanoma |
| Q26996059 | Micrometastatic cancer cells in lymph nodes, bone marrow, and blood: Clinical significance and biologic implications |
| Q37121669 | Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma |
| Q50158473 | Missed opportunity to diagnose subungual melanoma: potential pitfalls! |
| Q34115306 | Modelling population-based cancer survival trends using join point models for grouped survival data |
| Q34614180 | Molecular upstaging based on paraffin-embedded sentinel lymph nodes: ten-year follow-up confirms prognostic utility in melanoma patients |
| Q47437708 | Morbidity and Outcomes Following Axillary Lymphadenectomy for Melanoma: Weighing the Risk of Surgery in the Era of MSLT-II. |
| Q53349965 | Morphologic clues and utility of fluorescence in situ hybridization for the diagnosis of nevoid melanoma. |
| Q38015774 | Mucosal melanoma: pathogenesis, clinical behavior, and management |
| Q34372934 | Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burden |
| Q43568501 | Multiple lymphatic basin drainage from cutaneous melanoma as a prognostic factor. |
| Q55173262 | Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trial. |
| Q34315676 | Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases |
| Q43286130 | Neoadjuvant polychemotherapy in locally advanced Merkel cell carcinoma |
| Q56828372 | Neoplasms |
| Q37952237 | New developments in melanoma: utility of ultrasound imaging (initial staging, follow-up and pre-SLNB). |
| Q37528762 | Nodular Histologic Subtype and Ulceration are Tumor Factors Associated with High Risk of Recurrence in Sentinel Node-Negative Melanoma Patients. |
| Q36793361 | Nonparametric inference for assessing treatment efficacy in randomized clinical trials with a time-to-event outcome and all-or-none compliance |
| Q42590840 | Nonsentinel node metastases in melanoma: do they reflect the biology of the tumor, the lymph node or the surgeon? : Editorial to Accompany Ghaferi et al., ASO-2009-03-0312.R1. |
| Q44711648 | Observation after a positive sentinel lymph node biopsy in patients with melanoma |
| Q43705084 | Outcome of clinical stage III melanoma patients with FDG-PET and whole-body CT added to the diagnostic workup |
| Q36088981 | Outcome of patients with a positive sentinel lymph node who do not undergo completion lymphadenectomy. |
| Q35028465 | Outcomes for lymph node-positive cutaneous melanoma over two decades |
| Q27027762 | Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma |
| Q37919776 | Pathways for cervical metastasis in malignant neoplasms of the head and neck region |
| Q55620428 | Patterns of genomic evolution in advanced melanoma. |
| Q91263818 | Performance of a 31-gene expression profile test in cutaneous melanomas of the head and neck |
| Q53461340 | Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients. |
| Q33488307 | Photoacoustic detection of melanoma micrometastasis in sentinel lymph nodes |
| Q30403025 | Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination. |
| Q43973930 | Physicians differ on the use of sentinel lymph node biopsy for melanoma: published data receive various interpretations |
| Q37971305 | Positive lymph nodes do not metastasize |
| Q36692330 | Postoperative Complications following Nodal Dissection and Their Association with Melanoma Recurrence |
| Q42922868 | Potential cost-effectiveness of US-guided FNAC in melanoma patients as a primary procedure and in follow-up |
| Q79291184 | Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma |
| Q33579590 | Prediction of melanoma metastasis by the Shields index based on lymphatic vessel density |
| Q37348344 | Prediction of positron emission tomography/computed tomography (PET/CT) positivity in patients with high-risk primary melanoma |
| Q37455935 | Prediction of sentinel node status and clinical outcome in a melanoma centre |
| Q89824574 | Predictors of occult lymph node metastasis in cutaneous head and neck melanoma |
| Q33893833 | Predictors of occult nodal metastasis in patients with thin melanoma |
| Q33604742 | Predictors of sentinel lymph node metastasis in melanoma. |
| Q40733279 | Pregnancy and melanoma: a European-wide survey to assess current management and a critical literature overview. |
| Q35856660 | Preoperative ultrasound is not useful for identifying nodal metastasis in melanoma patients undergoing sentinel node biopsy: preoperative ultrasound in clinically node-negative melanoma |
| Q36791086 | Primary extraosseous Ewing sarcoma of the lung in children |
| Q38646098 | Principles of Melanoma Staging |
| Q34409481 | Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection |
| Q37726003 | Prognosis of patients with melanoma and microsatellitosis undergoing sentinel lymph node biopsy. |
| Q34140267 | Prognosis of sentinel node staged patients with primary cutaneous melanoma |
| Q84444645 | Prognostic factors in cutaneous desmoplastic melanoma: a study of 252 patients |
| Q34728451 | Prognostic false-positivity of the sentinel node in melanoma |
| Q37789673 | Prognostic implication of sentinel lymph node biopsy in cutaneous head and neck melanoma |
| Q36061720 | Prognostic role of sentinel lymph node biopsy for patients with cutaneous melanoma: A retrospective study of surveillance, epidemiology, and end-result population-based data |
| Q44808389 | Prognostic role of sentinel node biopsy in patients with thick melanoma: a meta-analysis. |
| Q52968768 | Prognostic significance of tumor mitotic rate in T2 melanoma staged with sentinel lymphadenectomy. |
| Q45180237 | Prognostic value of sentinel lymph node biopsy in 121 low-risk melanomas (tumour thickness <1.00 mm) on the basis of a long-term follow-up. |
| Q27001734 | Progression of cutaneous melanoma: implications for treatment |
| Q92002182 | Prospective cohort study of ultrasound surveillance of regional lymph nodes in patients with intermediate-risk cutaneous melanoma |
| Q50247600 | Prospective study of patterns of surgical management in adults with primary cutaneous melanoma at high risk of spread, in Queensland, Australia. |
| Q53509825 | Prospective study of sentinel node biopsy for high-risk cutaneous squamous cell carcinoma of the head and neck. |
| Q36072186 | Pump-probe imaging of pigmented cutaneous melanoma primary lesions gives insight into metastatic potential |
| Q37358268 | Quality of life after axillary or groin sentinel lymph node biopsy, with or without completion lymph node dissection, in patients with cutaneous melanoma |
| Q35099423 | Quantitative measurement of melanoma spread in sentinel lymph nodes and survival |
| Q54539741 | Quantitative real-time RT-PCR in sentinel lymph nodes from melanoma patients. Detection of melanocytic mRNA predicts disease-free survival. |
| Q46936342 | Radiation exposure to surgical staff during F-18-FDG-guided cancer surgery. |
| Q82674480 | Radiation versus resection for Merkel cell carcinoma |
| Q38352887 | Radiotherapy for cutaneous melanoma: current and future applications |
| Q40777119 | Rare vulvar malignancies; incidence, treatment and survival in the Netherlands. |
| Q38200004 | Recent developments in the medical and surgical treatment of melanoma |
| Q33983192 | Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution |
| Q53063931 | Refining the criteria for sentinel lymph node biopsy in patients with thinner melanoma: a roadmap for the future. |
| Q28087553 | Regional therapies for in-transit disease |
| Q43441918 | Relevance of multiple basin drainage and primary histologic regression in prognosis of trunk melanoma patients with negative sentinel lymph nodes |
| Q45842383 | Reliability and cost-effectiveness of complete lymph node dissection under tumescent local anaesthesia vs. general anaesthesia: a retrospective analysis in patients with malignant melanoma AJCC stage III. |
| Q44282859 | Reliability and cost-effectiveness of sentinel lymph node excision under local anaesthesia versus general anaesthesia for malignant melanoma: a retrospective analysis in 300 patients with malignant melanoma AJCC Stages I and II. |
| Q38585177 | Review of the role of sentinel node biopsy in cutaneous head and neck melanoma |
| Q50510106 | Robotically assisted fluorescence-guided lymph node mapping with ICG for gynecologic malignancies: a feasibility study. |
| Q36717715 | Role of lymphoscintigraphy and sentinel lymph node biopsy in the management of pediatric melanoma and sarcoma |
| Q37920831 | Role of selective sentinel lymph node dissection in head and neck melanoma |
| Q39434556 | Role of sentinel lymph node biopsy as a staging procedure in patients with melanoma: A critical appraisal. |
| Q87573784 | Role of sentinel lymph node biopsy in patients with Merkel cell carcinoma: statistical analysis of 403 reported cases |
| Q44893506 | Routine biopsy of cloquet's node is of limited value in sentinel node positive melanoma patients |
| Q52939378 | Routine usage of sentinel node biopsy in melanoma management must cease. |
| Q37425922 | S-100B concentrations predict disease-free survival in stage III melanoma patients |
| Q37079396 | SLN melanoma micrometastasis predictivity of nodal status: a long term retrospective study. |
| Q38777344 | SPECT/CT Improves Detection of Metastatic Sentinel Lymph Nodes in Patients with Head and Neck Melanoma |
| Q50213224 | SPECT/CT for SLN dissection in vulvar cancer: Improved SLN detection and dissection by preoperative three-dimensional anatomical localisation |
| Q53272038 | SPECT/CT for sentinel lymph node mapping in head and neck melanoma |
| Q33636148 | Semiconducting polymer dots with bright narrow-band emission at 800 nm for biological applications |
| Q38526523 | Sentinel Lymph Node Biopsy Provides Prognostic Value in Thick Head and Neck Melanoma |
| Q38401610 | Sentinel Lymph Node Biopsy Use Among Melanoma Patients 75 Years of Age and Older |
| Q91789610 | Sentinel Lymph Node Biopsy Was Associated With Favorable Survival Outcomes For Patients With Clinically Node-Negative Asian Melanoma |
| Q64236062 | Sentinel Lymph Node Biopsy and Complete Lymph Node Dissection for Melanoma |
| Q46580935 | Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update |
| Q37812813 | Sentinel Lymph Node Biopsy for Melanoma: Critical Assessment at its Twentieth Anniversary |
| Q38784286 | Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study |
| Q38757160 | Sentinel Lymph Node Biopsy in Thin Cutaneous Melanoma: A Systematic Review and Meta-Analysis |
| Q53132563 | Sentinel Lymph Node Characterization with a Dual-Targeted Molecular Ultrasound Contrast Agent. |
| Q50583302 | Sentinel Lymph Node Dissection in Head and Neck Melanoma has Prognostic Impact on Disease-Free and Overall Survival. |
| Q55262615 | Sentinel Node Biopsy in Melanoma: A Short Update. |
| Q44756636 | Sentinel Node Dissection Delays Recurrence and Prolongs Melanoma-Related Survival: An Analysis of 673 Patients from a Single Center with Long-Term Follow-Up |
| Q24201860 | Sentinel lymph node biopsy followed by lymph node dissection for early cutaneous melanoma |
| Q24187945 | Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma |
| Q40835747 | Sentinel lymph node biopsy for 102 patients with primary cutaneous melanoma at a single Japanese institute |
| Q53647601 | Sentinel lymph node biopsy for cutaneous melanoma: results of 10 years' experience in two regional training hospitals in the Netherlands. |
| Q37902717 | Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma: clinical experience and review of literature |
| Q44332123 | Sentinel lymph node biopsy for melanoma in pregnant women |
| Q34640145 | Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline |
| Q46134083 | Sentinel lymph node biopsy for melanoma: a plea to let the data speak |
| Q37236435 | Sentinel lymph node biopsy for melanoma: aspects of pathologic assessment. |
| Q37531858 | Sentinel lymph node biopsy for melanoma: indications and rationale |
| Q37646381 | Sentinel lymph node biopsy in Japan |
| Q38610915 | Sentinel lymph node biopsy in Merkel cell carcinoma: a 15-year institutional experience and statistical analysis of 721 reported cases |
| Q88093912 | Sentinel lymph node biopsy in cutaneous head and neck melanoma |
| Q51733578 | Sentinel lymph node biopsy in cutaneous melanoma. |
| Q43167662 | Sentinel lymph node biopsy in malignant melanoma |
| Q79819848 | Sentinel lymph node biopsy in melanoma |
| Q84994466 | Sentinel lymph node biopsy in melanoma management: its significance and potential problems |
| Q38190113 | Sentinel lymph node biopsy in melanoma: controversies and current guidelines |
| Q39173175 | Sentinel lymph node biopsy in melanoma: final results of MSLT-I. |
| Q34507667 | Sentinel lymph node biopsy in melanoma: our 8-year clinical experience in a single French institute (2002-2009) |
| Q51115955 | Sentinel lymph node biopsy in rats. Comparison between paraffin and frozen section analysis. |
| Q37478329 | Sentinel lymph node biopsy is a prognostic measure in pediatric melanoma |
| Q51020196 | Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma. |
| Q44590585 | Sentinel lymph node biopsy is associated with improved survival in Merkel cell carcinoma |
| Q35891758 | Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma |
| Q38945950 | Sentinel lymph node biopsy plus wide local excision vs. wide location excision alone for primary cutaneous melanoma: a systematic review and meta-analysis. |
| Q43218469 | Sentinel lymph node biopsy: Let's get back to basics in managing melanoma |
| Q37045206 | Sentinel lymph node evaluations |
| Q61801113 | Sentinel lymph node excision with or without preoperative hybrid single-photon emission computed tomography/computed tomography (SPECT/CT) in melanoma: study protocol for a multicentric randomized controlled trial |
| Q39342232 | Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations. |
| Q51098670 | Sentinel lymph node mapping in endometrial cancer: a concept ready for clinical routine? |
| Q48204704 | Sentinel lymph node mapping in endometrial cancer: comparison of fluorescence dye with traditional radiocolloid and blue. |
| Q38517435 | Sentinel lymph node procedure in endometrial cancer: A systematic review and proposal for standardization of future research |
| Q47726575 | Sentinel lymph node status as most important prognostic factor in patients with high-risk cutaneous melanomas (tumour thickness >4.00 mm): outcome analysis from a single institution |
| Q33326257 | Sentinel lymph-node false positivity in melanoma |
| Q24193688 | Sentinel node assessment for diagnosis of groin lymph node involvement in vulval cancer |
| Q24201030 | Sentinel node assessment for diagnosis of groin lymph node involvement in vulvar cancer |
| Q45346619 | Sentinel node biopsy and frozen section procedure in signet ring cell carcinoma of the eyelid and orbit |
| Q80755872 | Sentinel node biopsy confers no added protection to patients with melanoma |
| Q53582091 | Sentinel node biopsy in cutaneous melanoma: time for consensus to better inform patient choice. |
| Q33890196 | Sentinel node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute |
| Q81787038 | Sentinel node biopsy in patients with cutaneous melanoma of the head and neck: recurrence and survival study |
| Q35856609 | Sentinel node biopsy is indicated for thin melanomas ≥0.76 mm |
| Q83032213 | Sentinel node biopsy needs for a suitable therapeutic management of the cutaneous melanoma |
| Q80800359 | Sentinel node biopsy versus elective lymph node dissection in patients with cutaneous melanoma in a Japanese population |
| Q37541233 | Sentinel node mapping of VX2 carcinoma in rabbit thigh with CT lymphography using ethiodized oil |
| Q47611324 | Sentinel node metastasis mitotic rate (SN-MMR) as a prognostic indicator of rapidly progressing disease in patients with sentinel node-positive melanomas. |
| Q36281239 | Sentinel node studies in truncal melanoma: does an increased number of draining basins correlate with an increased risk of lymph metastasis? |
| Q52841570 | Sentinel-Lymphknoten-Biopsie des Melanoms mittels Indocyaningrün und "FOVIS"-System. |
| Q34580493 | Sentinel-lymph-node procedures in early stage cervical cancer: a systematic review and meta-analysis |
| Q83852238 | Sentinel-node biopsy in endometrial cancer: a win-win scenario? |
| Q42410816 | Sentinel-node biopsy in melanoma |
| Q41233576 | Sequencing of cancer cell subpopulations identifies micrometastases in a bladder cancer patient |
| Q34283488 | Serum Autoantibody Profiling Using a Natural Glycoprotein Microarray for the Prognosis of Early Melanoma |
| Q82674494 | Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy? |
| Q46752814 | Should patients being considered for surgical management in melanoma centers have their histology reviewed by specialized pathologists? |
| Q33517463 | Significance of sentinel lymph node biopsy in malignant melanoma: overview of international data. |
| Q33688976 | Simultaneous sentinel lymph node computed tomography and locoregional chemotherapy for lymph node metastasis in rabbit using an iodine-docetaxel emulsion |
| Q38213896 | Skin cancer - an overview for dentists |
| Q37497087 | So-called "malignant blue nevus": a clinicopathologic study of 23 patients |
| Q37873467 | Specific challenges in the management of subungual melanoma. |
| Q53053538 | Stage migration after minor changes in histologic estimation of tumor burden in sentinel lymph nodes: the protocol trap. |
| Q34625447 | Staging and prognosis of cutaneous melanoma |
| Q37370397 | Staging of regional lymph nodes in melanoma: a case for including nonsentinel lymph node positivity in the American Joint Committee on Cancer staging system |
| Q50507237 | Staging of regional nodes in pulmonary malignancies. |
| Q33693906 | State of melanoma: an historic overview of a field in transition |
| Q37271951 | State of the science 60th anniversary review: 60 Years of advances in cutaneous melanoma epidemiology, diagnosis, and treatment, as reported in the journal Cancer. |
| Q80969084 | Status of sentinel lymph nodes in cervical cancer |
| Q55055777 | Stratifying SLN incidence in intermediate thickness melanoma patients. |
| Q83327370 | Stromal expression of vascular endothelial growth factor C is relevant to predict sentinel lymph node status in melanomas |
| Q38027028 | Surgeons' opinions on lymphadenectomy in melanoma patients with positive sentinel nodes: a worldwide web-based survey |
| Q37266677 | Surgery and radiotherapy in the treatment of cutaneous melanoma |
| Q36393331 | Surgery and sentinel lymph node biopsy |
| Q30356095 | Surgery of primary melanomas. |
| Q38646103 | Surgical Management of Melanoma |
| Q39375962 | Surgical excision margin for primary acral melanoma |
| Q24240213 | Surgical excision margins for primary cutaneous melanoma |
| Q39743860 | Surgical management of melanoma: an EORTC Melanoma Group survey |
| Q38027415 | Surgical treatment of melanoma patients with early sentinel node involvement |
| Q42938255 | Survival and the sentinel lymph node in melanoma |
| Q52539731 | Targeting the duality of cancer. |
| Q30594885 | Technical effects of adding 1 % lidocaine to technetium sulfur colloid for sentinel lymphatic mapping in early breast cancer: analysis of data from a double-blind randomized controlled trial |
| Q38928358 | The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma |
| Q83147014 | The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution |
| Q88477729 | The best of both worlds: a hybrid approach for optimal pre- and intraoperative identification of sentinel lymph nodes |
| Q45907797 | The diagnostic value of adding dynamic scintigraphy to standard delayed planar imaging for sentinel node identification in melanoma patients. |
| Q36192538 | The evaluation of immunotherapy and chemotherapy treatment on melanoma: a network meta-analysis |
| Q92176245 | The extent of surgery for stage III melanoma: how much is appropriate? |
| Q61387631 | The impact of socioeconomic status on melanoma clinical trial participation: an observational cohort study from Australia |
| Q34268361 | The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I). |
| Q51375720 | The importance of mitosis as a factor for predicting sentinel lymph node biopsy for thin melanoma. |
| Q51124945 | The influence of sentinel lymph node biopsy on survival for intermediate-thickness melanoma. |
| Q36740669 | The influence of sentinel lymph node tumour burden on additional lymph node involvement and disease-free survival in cutaneous melanoma--a retrospective analysis of 392 cases |
| Q38016341 | The management of cervical lymph nodes in patients with cutaneous melanoma |
| Q36798179 | The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia |
| Q44857485 | The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasis |
| Q82472292 | The persistent anchor of lymph node removal in patients with melanoma |
| Q38267310 | The predictive value of single-photon emission computed tomography/computed tomography for sentinel lymph node localization in head and neck cutaneous malignancy |
| Q36952297 | The rationale for sentinel-node biopsy in primary melanoma |
| Q38024279 | The role of sentinel lymph node biopsy in the management of head and neck desmoplastic melanoma. |
| Q34584396 | The role of sentinel lymph node biopsy in the management of melanoma |
| Q37495524 | The sentinel node concept in prostate cancer: Present reality and future prospects |
| Q38594815 | The sentinel node procedure in early stage cervical cancer, taking the next step; a diagnostic review |
| Q37347488 | Therapeutic effect of sentinel lymph node biopsy in melanoma remains an open question |
| Q84337506 | Thick melanoma: prognostic value of positive sentinel nodes |
| Q34957433 | Thick primary melanoma has a heterogeneous tumor biology: an institutional series |
| Q80648270 | Three-dimensional visualisation of lymphatic drainage patterns in patients with cutaneous melanoma |
| Q44849673 | Three-dimensional visualization of skin lymphatic drainage patterns of the head and neck |
| Q45223882 | Too much surgery and too little benefit? Sentinel node biopsy for melanoma as it currently stands |
| Q37931078 | Treatment and prognostic significance of positive interval sentinel nodes in patients with primary cutaneous melanoma |
| Q39801051 | Treatment of cutaneous melanoma: current approaches and future prospects. |
| Q37534233 | Treatment of melanoma |
| Q64227861 | Trends in Sentinel Lymph Node Biopsy Enactment for Cutaneous Melanoma |
| Q35528902 | Trends in the treatment and survival for local and regional cutaneous melanoma in a US population-based study |
| Q37163843 | Tumor Cell Adhesion As a Risk Factor for Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma. |
| Q41320696 | Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases. |
| Q30541916 | Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses. |
| Q31052984 | Tumor cell plasticity and angiogenesis in human melanomas |
| Q48333472 | Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America. |
| Q91709268 | Tumor tissue hnRNP M and HSP 90α as potential predictors of disease-specific mortality in patients with early-stage cutaneous head and neck melanoma: A proteomics-based study |
| Q37197484 | Tumor-induced stromal reprogramming drives lymph node transformation |
| Q38105644 | Two new cases of metastatic basal cell carcinoma from the eyelids |
| Q37920830 | Ultrasound assessment of lymph nodes in the management of early-stage melanoma |
| Q36257430 | Underexpression of Specific Interferon Genes Is Associated with Poor Prognosis of Melanoma |
| Q51292847 | Ungual melanoma - controversies in diagnosis and treatment. |
| Q39165721 | University Hospital Waterford: 5-year experience of cutaneous melanoma |
| Q80811651 | Unusual histologic and clinical variants of melanoma: implications for therapy |
| Q37920834 | Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate |
| Q37656218 | Update on the sentinel lymph node procedure in vulvar cancer |
| Q33701984 | Use of fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastatic melanoma |
| Q37025939 | Use of ultrasound to early identify, diagnose and localize metastases in melanoma patients |
| Q38160653 | Utility of head and neck cutaneous squamous cell carcinoma sentinel node biopsy: a systematic review |
| Q30358585 | Utility of sentinel lymph node biopsy for solitary dermal melanomas. |
| Q37471964 | Validation of statistical predictive models meant to select melanoma patients for sentinel lymph node biopsy |
| Q39217100 | Value of sentinel lymph node biopsy in papillary thyroid cancer: initial results of a prospective trial |
| Q34321539 | Vascular endothelial growth factor receptor-3 directly interacts with phosphatidylinositol 3-kinase to regulate lymphangiogenesis. |
| Q30248851 | Weighing the value of completion nodal dissection for melanoma |
| Q40378050 | What is the pelvic lymph node normal size? Determination from normal MRI examinations |
| Q37131029 | What's new in dermatologic therapy |
| Q37983598 | When will selective lymphadenectomy become standard of care in melanoma? |
| Q42918170 | Who is to blame for false-negative sentinel node biopsies in melanoma? |
| Q42922902 | Why does no one want to perform lymph node dissection anymore? |
| Q48369014 | Why perform sentinel-lymph-node biopsy in patients with melanoma? |
| Q24188042 | Wound drainage following groin dissection for malignant disease in adults |
| Q24201418 | Wound drainage following groin dissection for malignant disease in adults |
| Q80347317 | [Complications after sentinel lymph node excision in patients with malignant melanoma] |
| Q80034323 | [Do the results of the Morton study affect the current melanoma management recommendations?] |
| Q81403426 | [Longitudinal study of different metastatic patterns in the progression of cutaneous melanoma] |
| Q86347919 | [Measuring quality in the German Guideline Programme in Oncology (GGPO)—methodology and implementation] |
| Q85642226 | [Sentinel lymph node biopsy and its diagnostic and therapeutic importance] |
| Q84357487 | [Sentinel lymph node biopsy in patients with melanoma] |
| Q81331234 | [The role of sentinel lymph node biopsy in the diagnosis and prognosis of malignant melanoma] |
| Q52956244 | [Therapy options for malignant eyelid tumors]. |
| Q81331230 | [Why does sentinel lymph node biopsy not increase survival in patients with melanoma?] |
Search more.